South Korea Sepsis Diagnostics Market Size & Outlook
- Clinical Diagnostics
- In Vitro Diagnostics
- Sepsis Diagnostics Market Outlook
- In Vitro Diagnostics
Global Market
Related Markets
Ask Prism AI about the sepsis diagnostics market
Get cited answers from GVR research on market growth, segments, regulations and forecasts.
- Source-linked answers
- Market-specific context
- Traceable figures
South Korea sepsis diagnostics market highlights
- The South Korea sepsis diagnostics market generated a revenue of USD 24.3 million in 2025 and is expected to reach USD 59.4 million by 2033.
- The South Korea market is expected to grow at a CAGR of 11.9% from 2026 to 2033.
- In terms of segment, conventional diagnostics was the largest revenue generating method in 2025.
- Automated Diagnostics is the most lucrative method segment registering the fastest growth during the forecast period.
Sepsis diagnostics market data book summary
| Market revenue in 2025 | USD 24.3 million |
| Market revenue in 2033 | USD 59.4 million |
| Growth rate | 11.9% (CAGR from 2026 to 2033) |
| Largest segment | Conventional diagnostics |
| Fastest growing segment | Automated Diagnostics |
| Historical data | 2021 - 2024 |
| Base year | 2025 |
| Forecast period | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Automated Diagnostics, Conventional Diagnostics |
| Key market players worldwide | BD, BioMerieux SA, Thermo Fisher Scientific Inc, Danaher Corp, Roche Holding AG ADR, Luminex, Koninklijke Philips NV, Bruker Corp, Cepheid, Immunexpress |
Other key industry trends
- In terms of revenue, South Korea accounted for 2.0% of the global sepsis diagnostics market in 2025.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
- In Asia Pacific, Japan sepsis diagnostics market is projected to lead the regional market in terms of revenue in 2033.
- China is the fastest growing regional market in Asia Pacific and is projected to reach USD 99.3 million by 2033.
The sepsis diagnostics market in South Korea is driven by technological advancements, government initiatives, rising sepsis incidence, and a robust healthcare infrastructure. According to a 2023 report by the Korean Society of Emergency Medicine, mortality rates from sepsis and septic shock in Korea remain significantly high.
Specifically, for septic shock, the in-hospital mortality rate is around 30%, highlighting the critical severity of this condition within the country’s healthcare system. The increasing geriatric population and limited awareness are making citizens more susceptible to sepsis.
These factors are collectively anticipated to propel market growth in the country. South Korea is at the forefront of integrating advanced technologies into its healthcare system. According to the report published by the Society of Critical Care Medicine.
No credit card required*
Publish Date: Jun 10, 2026
Customize the Report
20% free customization
- Include
- Countries, segments, points
- Tailor
- To your product definition
- Extend
- Deeper competitor detail
- Or
- A fully bespoke study
- Turnaround
- 5–10 working days
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Sepsis Diagnostics Market Scope
Sepsis Diagnostics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Roche Holding AG ADR | View profile | 103,605 | Grenzacherstrasse 124, Basel, Switzerland, 4070 | www.roche.com |
| Koninklijke Philips NV | View profile | 73,712 | Philips Center, Amstelplein 2, Amsterdam, Netherlands, 1096 BC | www.philips.com |
| BioMerieux SA | View profile | 13,982 | Marcy l’Etoile, Lyon, France, 69280 | www.biomerieux.com |
| Thermo Fisher Scientific Inc | View profile | 122,000 | 168 Third Avenue, Waltham, MA, United States, 02451 | www.thermofisher.com |
| Danaher Corp | View profile | 63,000 | 2200 Pennsylvania Avenue, N.W., Suite 800W, Washington, DC, United States, 20037-1701 | www.danaher.com |
| Bruker Corp | View profile | 9,707 | 40 Manning Road, Billerica, MA, United States, 01821 | www.bruker.com |
| BD | View profile | 10001+ | Franklin Lakes, New Jersey, United States, North America | www.bd.com |
| Luminex | View profile | 501-1000 | Austin, Texas, United States, North America | www.luminexcorp.com |
| Cepheid | View profile | 1001-5000 | Sunnyvale, California, United States, North America | www.cepheid.com |
| Immunexpress | View profile | 11-50 | Seattle, Washington, United States, North America | www.immunexpress.com |
South Korea Sepsis Diagnostics Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Sepsis Diagnostics Market Outlook will help companies and investors design strategic landscapes.
Conventional Diagnostics was the largest segment with a revenue share of 64.2% in 2025.
Horizon Databook has segmented the South Korea sepsis diagnostics market based on automated diagnostics, conventional diagnostics covering the revenue growth of each sub-segment from 2021 to 2033.
The sepsis diagnostics market in South Korea is driven by technological advancements, government initiatives, rising sepsis incidence, and a robust healthcare infrastructure. According to a 2023 report by the Korean Society of Emergency Medicine, mortality rates from sepsis and septic shock in Korea remain significantly high.
Specifically, for septic shock, the in-hospital mortality rate is around 30%, highlighting the critical severity of this condition within the country’s healthcare system. The increasing geriatric population and limited awareness are making citizens more susceptible to sepsis.
These factors are collectively anticipated to propel market growth in the country. South Korea is at the forefront of integrating advanced technologies into its healthcare system. According to the report published by the Society of Critical Care Medicine.
- South Korea Sepsis Diagnostics Market Method Outlook (Revenue, USD Million , 2021-2033)
- Automated Diagnostics
- Conventional Diagnostics
- South Korea Sepsis Diagnostics Market Technology Outlook (Revenue, USD Million , 2021-2033)
- Immunoassays
- Others
- Microbiology
- Flow Cytometry
- Molecular Diagnostics
- South Korea Sepsis Diagnostics Market Pathogen Outlook (Revenue, USD Million , 2021-2033)
- Bacterial Sepsis
- Fungal Sepsis
- Viral Sepsis and Others
- South Korea Sepsis Diagnostics Market Testing Type Outlook (Revenue, USD Million , 2021-2033)
- Laboratory Testing
- Point-of-Care Testing
- South Korea Sepsis Diagnostics Market End User Outlook (Revenue, USD Million , 2021-2033)
- Hospitals & Clinics
- Pathology & Reference Laboratories
- Research Institutes and Others
- South Korea Sepsis Diagnostics Market Product Outlook (Revenue, USD Million , 2021-2033)
- Instruments
- Blood Culture Media
- Assay Kits & Reagents
- Software
Reasons to subscribe to Sepsis Diagnostics Market Outlook databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Sepsis Diagnostics Market Outlook databook
- Our clientele includes a mix of Sepsis Diagnostics Market Outlook companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the South Korea Sepsis Diagnostics Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into South Korea Sepsis Diagnostics Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.
South Korea Sepsis Diagnostics Market, 2021-2033 (US$M)
South Korea sepsis diagnostics market statistics, by method, 2021-2033 (US$M)
